NEW! Investment Companies Centre

Genetix Group (GTX)

Sector:

Health Care Equipment & Services

Index:

techMARK

Market Cap

£29.43m

Change Today

Price Unchanged0.000p ()

Share Price

41.00p

Small caps round-up: Dawnay Day Treveria, Dragon Oil, GB, Independent Media,Danka

Date: Wednesday 16 Jul 2008

LONDON (ShareCast) - German property group Dawnay, Day Treveria says its assets and liquidity position are unaffected by current issues surrounding the Dawnay, Day Group, but it has not been not been able to get sufficient reassurance about the current financial stability of Dawnay, Day Treveria Real Estate Asset Management Limited, its asset manager.

Treveria is still talking to its asset managers, but says it is also looking at alternative managers.

Dragon Oil fell back on results from its latest test drill in the Caspian Sea. Development well Dzheitune (Lam) 22/128 yielded a combined rate of 2,600 barrels of oil per day from the short and long strings following initial testing.The company added that completion of well Dzheitune (Lam) A/129 is scheduled for August 2008.

Customer monitoring software group GB's progress continued with a 41,000 profit in the first quarter compared with a £665,000 loss. Revenues rose 57% to £5.75m compared to £3.67m in same period last year. Underlying revenues in the three months to June rose 47% to £5.4m.

"The ability to prove age and identity electronically and subsequently to manage customers effectively over the internet is a prerequisite for every on line business and GB is exceptionally well placed to address this growing market," chief executive Richard Law.

Digital ad specialist Independent Media expects to announce revenue for the half year to rise 14% and the pre-tax profit to be at least 30% ahead of last year.

The group said it has continued to trade strongly despite the ensuing economic turbulence.

"These results will show strong performance for the UK business balanced against investment in developing the Group's operations in Continental Europe," it said.

Cancer diagnostic group Genetix said revenue for the six months to June is expected to rise 19%, driven by strong organic growth in clinical instruments and its cell biology products.

“We expect to see continued sales growth in the second half, although the growth rate seen in the first half of the current year has been enhanced by customers' purchasing cycles,” said the group.

Diamond miner Firestone Diamond said it has placed 5.8m new ordinary shares at a price of 85p each to raise £5m before expenses.

Immune systems developer Norwood has signed a six-month exclusive collaboration agreement with Medimmune, a recognized leader in vaccine research and development.

Norwood will receive an exclusivity fee from Medimmune and will also be reimbursed costs associated with performing collaborative research using certain MedImmune vaccine candidates and Norwood's virosome technology.

Shares in ANT rose after it announced that set top box supplier Unihan, a subsidiary of the Taiwanese IT products company AsusTek, had licensed the digital TV software provider’s browser for its products.

“Unihan has a proven record in rolling out successful set-top box solutions in high volumes,” ANT chief executive Simon Woodward said.

Danka Business Systems narrowed its full year net loss from continuing operations to $29.3m for the year ended 31 March 2008, down from $48.7m the year before. Revenue fell 7% to $418.2m.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genetix Group Market Data

Currency UK Pounds
Share Price 41.00p  
Closing Price Change 0.000p
52 Week High 62.50
52 Week Low 35.00
Volume 0
Shares Issued 71.78m
Market Cap £29.43m
Beta 0.11
RiskGrade 203

Performance Indicators

Compare performance with the sector and the market.
Find out more
Key: vs Market vs Sector
Value
65.11% below the market average65.11% below the market average65.11% below the market average65.11% below the market average65.11% below the market average
20.83% below the sector average20.83% below the sector average20.83% below the sector average20.83% below the sector average20.83% below the sector average
Price Trend
50.31% above the market average50.31% above the market average50.31% above the market average50.31% above the market average50.31% above the market average
55.10% above the sector average55.10% above the sector average55.10% above the sector average55.10% above the sector average55.10% above the sector average
Income
91.7% below the market average91.7% below the market average91.7% below the market average91.7% below the market average91.7% below the market average
57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average
Growth
42.57% above the market average42.57% above the market average42.57% above the market average42.57% above the market average42.57% above the market average
2.22% above the sector average2.22% above the sector average2.22% above the sector average2.22% above the sector average2.22% above the sector average
Price Chg 6m
29.85% above the market average29.85% above the market average29.85% above the market average29.85% above the market average29.85% above the market average
34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average34.69% above the sector average
P/E
18.3% below the market average18.3% below the market average18.3% below the market average18.3% below the market average18.3% below the market average
13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average13.04% below the sector average
PEG
45.74% below the market average45.74% below the market average45.74% below the market average45.74% below the market average45.74% below the market average
53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average
Dividend Yield
88.11% below the market average88.11% below the market average88.11% below the market average88.11% below the market average88.11% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
EPS Growth
5.58% below the market average5.58% below the market average5.58% below the market average5.58% below the market average5.58% below the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average
Operating Margin
10.81% above the market average10.81% above the market average10.81% above the market average10.81% above the market average10.81% above the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average

Genetix Group Dividends

  Latest Previous
  Interim Final
Ex-Div 13-Aug-08 07-May-08
Paid 12-Sep-08 09-Jun-08
Amount 0.20p 0.50p

Trades for --2008

Time Volume / Share Price
0 @ 0.000p

Genetix Group Key Personnel

Finance Director Andrew Kellett
CEO Charles de Rohan

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).